Swerdlow SH Campo E Harris NL WHO classification of tumours of haematopoietic and lymphoid tissues 2008 Lyon IARC 
Tefferi A Thiele J Orazi A Kvasnicka HM Barbui T Hanson CA Barosi G Verstovsek S Birgegard G Mesa R Reilly JT Gisslinger H Vannucchi AM Cervantes F Finazzi G Hoffman R Gilliland DG Bloomfield CD Vardiman JW Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel Blood 2007 110 4 1092-1097 
Thiele J Kvasnicka HM Facchetti F Franco V Walt J Orazi A European consensus on grading bone marrow fibrosis and assessment of cellularity Haematologica 2005 90 1128-1132 
Fend F Horn T Koch I Vela T Orazi A Atypical chronic myeloid leukemia as defined in the WHO classification is a JAK2 V617F negative neoplasm Leuk Res 2008 32 12 1931-1935 
Wardrop D Steensma DP Is refractory anaemia with ring sideroblasts and thrombocytosis (RARS-T) a necessary or useful diagnostic category? Br J Haematol 2009 144 6 809-817 
Ades L Boehrer S Prebet T Beyne-Rauzy O Legros L Ravoet C Dreyfus F Stamatoullas A Chaury MP Delaunay J Laurent G Vey N Burcheri S Mbida RM Hoarau N Gardin C Fenaux P Efficacy and safety of lenalidomide in intermediate-2-or high risk myelodysplastic syndromes (MDS) with 5q deletion: Results of a phase II study Blood 2009 113 17 3947-3952 
